Spain Honors Ana Fernandez-Sesma, PhD, Chair of Mount Sinai’s Department of Microbiology
Recognizes her for scientific work in the United States with the Camino Real Award From the Benjamin Franklin Research Institute of the University of Alcala in Spain
Photo Credit: Casa Real de España (Royal House of Spain).
Ana Fernandez-Sesma, PhD, Chair of the Department of Microbiology at the Icahn School of Medicine at Mount Sinai and an investigator who is distinguished for her experience and expertise in virology, vaccinology, immunology, and microbiology, is the recipient of the 2023 Camino Real Award from the Instituto Franklin de la Universidad de Alcala in Spain. The award recognizes Dr. Fernandez-Sesma for the development of her work at Icahn Mount Sinai since 1991, and for her position as a world reference for studies related to pathogens that cause infectious diseases.
Spain’s King Felipe VI presented Dr. Fernandez-Sesma with the award on Thursday, July 13, during a ceremony at the University of Alcala in Madrid, Spain. During the ceremony, King Felipe remarked that this award recognizes the exemplary professional trajectory of a Spaniard who, through her work at Icahn Mount Sinai over the years, has demonstrated great human values, mentoring, and public commitment, projecting a very positive image of Spain in the United States.
During her acceptance speech, Dr. Fernandez-Sesma, the first woman to receive the award, expressed how honored she felt in receiving this recognition, as both a Spanish and American citizen, and her great appreciation for the opportunities that both countries have given her. She highlighted how her education and upbringing in Spain prepared her very well for a career abroad and that she “landed” in the perfect place in the United States— Icahn School Mount Sinai—to pursue her scientific career.
The Instituto Franklin de la Universidad de Alcala is dedicated to the study of North America and is named after Benjamin Franklin. Founded in 1987, the Institute’s activity focuses on postgraduate research and education related to American Studies and Bilingual Education through research projects, scholarships, and grants. The Institute’s mission is to serve as a platform for communication, cooperation, and union between Spain and North America, in order to promote mutual understanding.
Dr. Fernandez-Sesma has distinguished herself as an investigator focused on the mechanisms of immune evasion used by viruses, including dengue, influenza, the human immunodeficiency virus, Zika, and SARS-CoV-2, the virus that causes COVID-19, to establish infection in humans. Her research has uncovered the mechanisms used by RNA viruses, such as dengue, to circumvent the host immune responses and the role of cellular elements, such as mitochondrial DNA, to alert the immune system after RNA viral infections.
Dr. Fernandez-Sesma has been ranked among the top National Institutes of Health (NIH)-funded investigators in microbiology in the United States. She was a member of the Division of Infectious Diseases and Microbiology Scientific Advisory Council of the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH from 2018 to 2022, when she also chaired the NIH/NIAID Human Immunology Project Consortium Steering Committee. Currently, she participates in several NIH-funded multi-investigator projects and is the lead investigator of the Viral Immunity and Vaccination Human Immunology Project Consortium.
Dr. Fernandez-Sesma was born in Caceres, Spain, and graduated from the University of Salamanca, also in Spain, with a degree in Biological Sciences. Dr. Fernandez-Sesma is an alumna of Icahn Mount Sinai, having earned her PhD in Biomedical Science there.
Previous recipients of the Camino Real Award are tennis player Rafael Nadal (2022), actor Antonio Banderas (2017), basketball player Pau Gasol (2015), world-renowned Mount Sinai cardiologist Valentín Fuster, MD, PhD (2013), and tenor Plácido Domingo (2012).
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.
Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 44 academic departments and 36 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.
Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.
A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.
Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.
Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.
The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
To find more information about the Camino Real Award just click here.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.